Liver subcapsular hematoma caused by Fasciola hepatica. Report of one case;Hematoma subcapsular por Fasciolasis

Revista Chilena de Cirugia

Volumn 61, Issue 1, 2009, Pages 73-77

  Morales G, Juan L ^a   Arriagada H, Renato ^a   Salas G, Luis ^a   Morales A, Carlos ^b   Fuentes A, Felipe ^b   Santana I, Roberto ^b  

^a Servicio de Cirugía Hospital Herminda Martin   (Chile)

^b UNIVERSIDAD CATÓLICA DE LA SANTÍSIMA CONCEPCIÓN   (Chile)

Author keywords

Fasciola hepatica; Liver; Subcapsular hematoma

Indexed keywords

EID: 67649664077     PISSN: 03793893     EISSN: 07184026     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Atias A, Neghme A. Fasciolasis. En: Parasitología Clínica. Santiago: Editorial Mediterráneo 1991; 334-340.
2. Cywiñska A. Epidemiology of fascioliasis in human endemic areas. J Helminthol 2005; 79: 207-216.
3. Haseeb A, El-Shazly A, Arafa M, Morsy A. A review on fascioliasis in Egypt. J Egypt Soc Parasitol 2002; 32: 317-354.
4. Atias A. Fasciolasis. En: Parasitología Médica. Santiago: Editorial Mediterráneo, 1998: 375-381.
5. Apt W, Aguilera X, Vega F. Prevalence of fasciolasis in humans horses, pigs, and wild rabbits in 3 chilean provinces. Bol Of Sanit Panam 1993; 115: 405-414.
6. Chan C, Lam S. Diseases caused by liver flukes and cholangiocarcinoma. Baillieres Clin Gastroenterol 1987; 1: 297-318.
7. Maclean J, Cross J, Mahanty S. Liver, lung, and intestinal fluke infections. En: Tropical Infectious Diseases: Principles, Pathogens and Practice. Philadelphia, Churchill Livingstone, 2006: 1349-1357.
8. Arjona R, Riancho A, Aguado J, Salesa R, González-Macías R. Fascioliasis in developed countries: a review of classic and aberrant forms of the disease. Medicine 1995; 74: 13-23.
9. Hillyer G, Soler de Galanes M, Rodríguez-Pérez J, Bjorlan J, Silva de Lagrava M, Ramírez S, et al. Use of the Falcon assay screening test--enzyme-linked immunosorbent assay (FAST-ELISA) and the enzyme-linked immunoelectrotransfer blot (EITB) to determine the prevalence of human fascioliasis in the Bolivian Altiplano. Am J Trop Med Hyg 1992; 46: 603-609.
10. Van Beers B, Pringot J, Geubel A, Trigaux J, Bigaignon J, Domms G. Hepatobiliary fascioliasis: noninvasive imaging findings. Radiology 1990; 174: 809-810.
11. Sezgin O, Altintas E, Disibeyaz S, Saritas U, Sahin B. Hepatobiliary fascioliasis: clinical and radiologic features and endoscopic management. J Clin Gastroenterol 2004; 38: 285-291.
12. Rossignol J, Abaza H, Friedman, H. Successful treatment of human fascioliasis with nitazoxanide. Trans R Soc Trop Med Hyg 1998; 92: 103-104.
13. Bacq Y, Besnier J, Duong T, Pavie G, Metman E, Choutet G. Successful treatment of acute fascioliasis with bithionol. Hepatology 1991; 14: 1066-1069.
14. Keiser J, Utzinger J. Chemotherapy for major food-borne trematodes: a review. Expert Opin Pharmacother 2004; 5: 1711-1726.
15. El-Karaksy H, Hassanein B, Okasha S, Behairy B, Gadallah I. Human fascioliasis in Egyptian children: successful treatment with triclabendazole. J Trop Pediatr 1999; 45: 135-138.
16. Richter J, Freise S, Mull R, Millan J. Fascioliasis: sonographic abnormalities of the biliary tract and evolution after treatment with triclabendazole. Trop Med Int Health 1999; 4: 774-781.
17. Spithill T, Piedrafita D, Smooker P. Immunological approaches for the control of fasciolosis. Int J Parasitol 1997; 27: 1221-1235.